In Australia, is Addyi (Flibanserin) available or what is available?

 Australia Leads the Way in Androgen Treatment for Women with HSDD

While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s not approved in Australia—and comes with notable side effects.

Instead, Australia is the only country in the world to approve a regulated androgen hormone treatment specifically for postmenopausal women with HSDD. This topical therapy restores androgen levels to those typical of premenopausal women and is backed by decades of Australian-led research.

This marks a major step forward in addressing gender equity in sexual health care.